ReviewCurrent cardiology reports2022

Role of Monotherapy with a P2Y12 Inhibitor for Secondary Prevention in Patients with Established Atherosclerosis.

Juan J Rodriguez et al.PubMed ↗Publisher ↗

No numbers read from the abstract.